Developer of first-in-class immune-modulators to target diseases of the immune system. The company has clinically validated a first-in-class immune checkpoint regulator mechanism to selectively target...

Drug Discovery
Healthcare
San Francisco, CA, United States
Founded 2000
30 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$336.6M
Last Round
Later Stage VC (Series B)
May 2024

Get the full picture

Create a free account to unlock AltruBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required